| Assertion (A): | Conventional breeding is not the answer if we want to increase yield in the existing crop varieties. |
| Reason (R): | The existing crop varieties have evolved into new species and traditional hybridisation is not possible now. |
| 1. | Both (A) and (R) are False. |
| 2. | Both (A) and (R) are True but (R) does not explain (A). |
| 3. | (A) is True but (R) is False. |
| 4. | Both (A) and (R) are True and (R) explains (A). |
| 1. | More tolerance to abiotic stresses |
| 2. | Alternative resources to industries |
| 3. | Increased efficiency of mineral usage by plants |
| 4. | Fixation of atmospheric nitrogen |
| Statement I: | Bt toxin is more environmentally friendly than synthetic pesticides. |
| Statement II: | Expression of Bt toxin gene in plants provide resistance of certain insects. |
| 1. | Statement I is correct and Statement II is incorrect |
| 2. | Both Statement I and Statement II are correct and Statement II explains Statement I |
| 3. | Both Statement I and Statement II are correct but Statement II does not explain Statement I |
| 4. | Statement I is incorrect and Statement II is correct |
| I: | Any Bt toxin gene isolated from Bacillus thuringiensis can be used to create GM crops resistant to all insects. |
| II: | Bt toxins do not have specificity for any insect groups. |
| 1. | Statement I is correct and Statement II is incorrect. |
| 2. | Both Statement I and Statement II are correct and Statement II explains Statement I. |
| 3. | Both Statement I and Statement II are correct but Statement II does not explain Statement I. |
| 4. | Both Statement I and Statement II are incorrect. |
| 1. | a nematode, Meloidogyne incognita. |
| 2. | a nematode, Caenorhabditis elegans. |
| 3. | a trematode, Clonorchis sinensis. |
| 4. | a cestode, Taenia sloium. |
| I: | An infection by viruses having RNA genomes |
| II: | Mobile genetic elements that replicate via an RNA intermediate |
| III: | Integration of phage DNA into the main chromosomal DNA of a eukaryotic cell |
| 1. | Only I and II | 2. | Only I and III |
| 3. | Only II and III | 4. | I, II and III |
| Assertion (A): | In most cases, recombinant therapeutics are safer than similar products isolated from non-human sources. |
| Reason (R): | Recombinant therapeutics do not induce unwanted immunological responses. |
| 1. | Both (A) and (R) are True and (R) correctly explains (A). |
| 2. | (A) is True but (R) is False. |
| 3. | Both (A) and (R) are True but (R) does not explain (A). |
| 4. | Both (A) and (R) are False. |
| I: | All diabetics require insulin from the very beginning. |
| II: | Insulin can be given orally to diabetics. |
| III. | Insulin extracted from pancreas of slaughtered cattle and pigs caused some patients to develop allergy. |
| IV. | Recombinant insulin was first prepared by Indian pharmaceutical giant Ranbaxy. |
| V. | The two polypeptide chains in the final structure of Insulin are joined by disulfide bonds. |
| VI. | DNA sequences corresponding to A and B chains of human insulin were introduced in plasmids of E.coli to produce insulin chains for preparing recombinant insulin. |
| 1. | 2 | 2. | 3 |
| 3. | 4 | 4. | 5 |
| Assertion (A): | Correction of a gene defect by gene therapy involves delivery of a normal copy of gene into the individual or embryo. |
| Reason (R): | The normal copy of gene delivered takes over the function of and compensates for the non-functional gene. |
| 1. | Both (A) and (R) are False. |
| 2. | (A) is True but (R) is False. |
| 3. | Both (A) and (R) are True but (R) does not explain (A). |
| 4. | Both (A) and (R) are True and (R) explains (A). |
| Assertion (A): | Deficiency of the enzyme adenosine deaminase causes severe combined immunodeficiency. |
| Reason (R): | This disorder is caused due to the deletion of the gene for adenosine deaminase. |
| 1. | Both (A) and (R) are True but (R) does not explain (A). |
| 2. | (A) is True but (R) is False. |
| 3. | Both (A) and (R) are False. |
| 4. | Both (A) and (R) are True and (R) explains (A). |